Skip to main content
logo
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
45.54
+1.28 (2.89%)
At close: Oct 23, 2025, 4:00 PM EDT
43.99
-1.55 (-3.40%)
After-hours: Oct 23, 2025, 7:58 PM EDT

Revenue by Product

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
HIV
7.09B
Log In
Log In
Log In
Log In
Upgrade
HIV Growth
8.08%
Log In
Log In
Log In
Log In
Upgrade
Other
-30.77B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
3.94%
Log In
Log In
Log In
Log In
Upgrade
Meningitis
1.44B
Log In
Log In
Log In
Log In
Upgrade
Meningitis Growth
15.57%
Log In
Log In
Log In
Log In
Upgrade
Influenza
408.00M
Log In
Log In
Log In
Log In
Upgrade
Influenza Growth
-19.22%
Log In
Log In
Log In
Log In
Upgrade
Established Vaccines
3.34B
Log In
Log In
Log In
Log In
Upgrade
Established Vaccines Growth
1.85%
Log In
Log In
Log In
Log In
Upgrade
Shingles
3.36B
Log In
Log In
Log In
Log In
Upgrade
Shingles Growth
-5.78%
Log In
Log In
Log In
Log In
Upgrade
Oncology
1.41B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
56.57%
Log In
Log In
Log In
Log In
Upgrade
Respiratory, Immunology and Inflammation
3.30B
Log In
Log In
Log In
Log In
Upgrade
Respiratory, Immunology and Inflammation Growth
10.76%
Log In
Log In
Log In
Log In
Upgrade
Respiratory
7.21B
Log In
Log In
Log In
Log In
Upgrade
Respiratory Growth
-0.74%
Log In
Log In
Log In
Log In
Upgrade
Other General Medicines
3.22B
Log In
Log In
Log In
Log In
Upgrade
Other General Medicines Growth
-6.92%
Log In
Log In
Log In
Log In
Upgrade
Total Commerical Operations
31.38B
Log In
Log In
Log In
Log In
Upgrade
Total Commerical Operations Growth
0.59%
Log In
Log In
Log In
Log In
Upgrade
Total Consumer Healthcare
-
Log In
Log In
Log In
Log In
Upgrade
Pandemic
-
Log In
Log In
Log In
Log In
Upgrade
Pandemic Growth
-
Log In
Log In
Log In
Log In
Upgrade
Pandemic Vaccines
-
Log In
Log In
Log In
Log In
Upgrade
Pandemic Vaccines Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-30.77B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
3.94%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Other
-3.31B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
318.53%
Log In
Log In
Log In
Log In
Upgrade
Commercial Operations Segment Profit
15.34B
Log In
Log In
Log In
Log In
Upgrade
Commercial Operations Segment Profit Growth
-0.47%
Log In
Log In
Log In
Log In
Upgrade
Research & Development Segment Profit
-5.85B
Log In
Log In
Log In
Log In
Upgrade
Research & Development Segment Profit Growth
2.08%
Log In
Log In
Log In
Log In
Upgrade
Consumer Healthcare Segment Profit
-
Log In
Log In
Log In
Log In
Upgrade
Other
-3.31B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
318.53%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
US Revenue
16.38B
Log In
Log In
Log In
Log In
Upgrade
US Revenue Growth
-0.97%
Log In
Log In
Log In
Log In
Upgrade
Europe
6.67B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
6.94%
Log In
Log In
Log In
Log In
Upgrade
International
8.33B
Log In
Log In
Log In
Log In
Upgrade
International Growth
-1.28%
Log In
Log In
Log In
Log In
Upgrade